Effect of Risedronate on the Risk of Hip Fracture in Elderly Women

20011,922 citationsletterbronze Open Access

Authors

Michael R. McClung · Bone Health and Osteoporosis Foundation

Piet Geusens · Maastricht University

Paul D. Miller · Colorado Center for Bone Research

H Zippel · Charité - Universitätsmedizin Berlin

W. Bensen · St. Joseph's Hospital

Christian Roux · Hôpital Cochin

Silvano Adami

Abstract

Risedronate significantly reduces the risk of hip fracture among elderly women with confirmed osteoporosis but not among elderly women selected primarily on the basis of risk factors other than low bone mineral density.

Topics & Keywords

Bone health and osteoporosis research Bone health and treatments Hip and Femur Fractures

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 344, Issue 5, pp. 333-340

DOI: 10.1056/nejm200102013440503

Field-Weighted Citation Impact: 99.03